UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 13, 2014

 

 

VERITEQ CORPORATION
(Exact name of registrant as specified in its charter)

 

DELAWARE

 

000-26020

 

43-1641533

(State or other Jurisdiction of Incorporation)

 

(Commission File Number)

 

(IRS Employer Identification No.)

 

220 CONGRESS PARK DRIVE, SUITE 200
DELRAY BEACH, FLORIDA

 

33445

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: 561-846-7000

 

 

(Former name or former address if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



 
 

 

 

Item 4.02

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.

 

On August 13, 2014, the board of directors (the “Board”) of VeriTeQ Corporation (the “Company”) concluded that the previously issued audited financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013 (the “Original 10-K”) and the unaudited condensed consolidated financial statements contained in the Company’s Quarterly Report on Form 10-Q for the three-months ended March 31, 2014 (the “Original 10-Q”) should no longer be relied upon because of errors in those financial statements relating to the Company’s accounting for the embedded conversion option contained in convertible notes that were issued on November 13, 2013.

 

On November 13, 2013, the Company entered into a financing transaction, which included convertible notes in the principal amount of $1,816,667. The notes are convertible into shares of the Company’s common stock at an initial exercise price of $0.75 per share. The notes provided for the initial conversion price to be reset to lower amounts in the event the Company issues its common stock or is deemed to have issued its common stock at a price below the conversion price in effect at that time. This provision results in what is referred to as an embedded derivative and should have been bifurcated and a liability recorded for the embedded derivative at fair value upon the issuance of the notes and on December 31, 2013 in the Original 10-K and on March 31, 2014 in the Original 10-Q. This oversight resulted in an understatement of the non-cash embedded derivative liability of $3.1 million and $2.1 million at December 31, 2013 and March 31, 2014, respectively. Accordingly, we are restating our previously filed financial statements to reflect the fair value of this embedded derivative as a current liability on our consolidated balance sheets at December 31, 2013 and March 31, 2014 and to reflect the initial fair value and change in the fair value from November 13, 2013 to December 31, 2013 and from December 31, 2013 to March 31, 2014 in our financial statements as presented below. We are also restating certain unaudited pro forma results related to a business combination for the year ended December 31, 2013. The correction of the error did not impact any assets.

 

The effect of the restatement on each of our financial statements at and as of December 31, 2013 and for the period from December 14, 2011 (Inception) to December 31, 2013 and at and as of March 31, 2014 and for the period from December 14, 2011 (Inception) to March 31, 2014, as well as certain unaudited pro forma information for the year ended December 31, 2013 is as follows:

 

 

Consolidated Balance Sheets Data 

(in thousands)

 

 

 

As Previously Reported

December 31,

 

 

As Restated December 31,

 

 

 

2013

 

 

2013

 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

 

 

 

 

 

 

 

Liabilities for conversion option of the convertible notes

 

$

   

$

3,124

 

Total current liabilities

 

$

4,250

 

 

$

7,374

 

Total liabilities

 

$

19,229

 

 

22,353

 

Accumulated deficit during the development stage

 

(16,700

)

 

$

(19,824

)

Total stockholders’ deficit

 

$

(11,010

)

 

(14,143

)

 

 

Consolidated Statements of Operations Data

 (in thousands, except per share data)

 

 

 

For the Year

Ended

December 31,

2013 As Previously Reported

 

 

For the Year

Ended

December 31,

2013 As Restated

 

 

   

Other expense

 

4,164

 

 

4,527

 

 

     
Interest expense   $ 4,335     $ 7,096          

Loss before income taxes

 

$

(15,077

)

 

(18,201

)

 

     

Net loss

 

$

(15,077

)

 

$

(18,201

)

 

     

Net loss per common share — basic and diluted

 

$

(1.75

)

 

$

(2.11

)

 

     

 

 
 

 

 

 

 

For the Period from

December 14,

2011 (Inception to December 31, 2013

As Previously Reported

 

 

For the Period from December 14, 2011 (Inception) to

December 31,

2013 as Restated

 

Other expense

 

$

4,164

 

 

4,527

 

Interest expense   $ 4,468     $ 7,229  

Loss before income taxes

 

(17,500

)

 

$

(20,624

)

Net loss

 

$

(16,700

)

 

$

(19,824

)

 

 

Consolidated Statements of Comprehensive Loss Data

 (in thousands)

 

 

 

Year Ended

December 31,

 

 

   

 

 

2013 As Previously Reported

 

 

2013

As Restated

 

 

     

Net loss

 

$

(15,077

)

 

$

(18,201

)

 

     

Comprehensive loss

 

$

(15,077

)

 

$

(18,201

)

 

     

 

 

 

From

December 14, 2011 (Inception)

to December 31,

2013 As Previously Reported

   

From

December 14, 2011 (Inception)

to December 31,

2013 As Restated

 

 

   

Net loss

 

$

(16,700

)

 

$

(19,824

)

 

     

Comprehensive loss

 

$

(16,700

)

 

$

(19,824

)

 

     

 

 

Consolidated Statement of Changes in Stockholders’ Deficit Data

(in thousands)

 

 

 

As Previously Reported

 

 

As Restated

 

Net loss for the year ended December 31,2013

 

$

(15,077

)

 

$

(18,201

)

Accumulated deficit at December 31, 2013

 

$

(16,700

)

 

$

(19,824

)

Total stockholders’ deficit at December 31, 2013

 

$

(11,010

)

 

$

(14,134

)

 

 

Consolidated Statements of Cash Flows Data

(in thousands)

 

 

 

For the Year

Ended

December 31,

2013 As Previously Reported

 

 

For the Year

Ended

December 31,

2013 As Restated

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

Net loss

 

$

(15,077

)

 

$

(18,201

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Non-cash interest expense

  $ 3,873     $ 6,634  

Change in fair value of conversion option of the convertible notes 

 

$

   

$

363

 

 

 
 

 

  

 

 

 

For the Period from December 14, 2011 (Inception) to

December 31,

2013 As Previously Reported

 

 

For the Period from December 14, 2011 (Inception) to

December 31,

2013 As Restated

 

 

   

 

 

 

 

 

 

 

 

 

 

     

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

     

Net loss

 

$

(16,700

)

 

$

(19,824

)

 

     

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

 

     

Non-cash interest expense

  $ 3,991     $ 6,752          

Change in fair value of conversion option of the convertible notes 

 

$

   

$

363

         

 

 

Pro Forma Information

 

Unaudited pro forma results of operations for the year ended December 31, 2013 as originally reported and as restated is presented below.

 

(In thousands, except per share amounts)

 

Year Ended

December 31, 2013 As Previously Reported

 

 

Year Ended
December 31, 2013 As Restated

 

Net loss

 

$

(15,453

)

 

$

(18,577

)

Net loss per common share – basic and diluted

 

$

(1.69

)

 

$

(2.03

)

 

 

Unaudited Condensed Consolidated Balance Sheets Data

(in thousands)

 

 

 

As Previously Reported

March 31,

 

 

As Restated

March 31,

 

 

 

2014

 

 

2014

 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Liabilities for conversion option of the convertible notes

 

$

   

$

2,054

 

Total current liabilities

 

$

5,866

 

 

7,920

 

Total liabilities

 

15,190

 

 

$

17,244

 

Accumulated deficit during the development stage

 

(13,145

)

 

(15,199

)

Total stockholders’ deficit

 

(7,212

)

 

$

(9,266

)

 

 

Unaudited Condensed Consolidated Statements of Operations Data

 (in thousands, except per share data)

 

 

 

For the Three-Months Ended

March 31,

2014 As Previously Reported

 

 

For the Three-Months

Ended

March 31,

2014 As Restated

 

 

   

 

 

 

 

 

 

 

 

 

 

     

Change in value of conversion option of the convertible notes

 

$

   

$

1,070

         

 Total other income (expense)

 

 5,038

 

 

$

6,108

 

 

     

Income before income taxes

 

3,555

 

 

4,625

 

 

     

Net income

 

$

3,555

 

 

$

4,625

 

 

     

Net income per common share — basic

 

$

0.37

 

 

$

0.48

 

 

     

Net income per common share — diluted

 

$

0.09

 

 

$

0.17

 

 

     

 

 

 
 

 

 

 

 

For the Period from

December 14,

2011 (Inception to March 31, 2014

As Previously Reported

 

 

For the Period from December 14, 2011 (Inception) to

March 31,

2014

As Restated

 

 

 

 

 

 

 

 

 

 

Change in value of conversion option of the convertible notes

 

$

   

$

707

 

Interest expense

 

$

(4,929

 

$

(7,690

 Total other income (expense)

 

 (3,594

 

(5,648

Loss before income taxes

 

(13,945

)

 

(15,999

Net loss

 

$

(13,145

)

 

$

(15,199

 

 

Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) Data

 (in thousands)

 

   

Three-Months Ended

March 31,

         
   

2014

As Previously Reported

   

2014

As Restated

         

Net income (loss)

  $ 3,555     $ 4,625

 

       

Comprehensive income (loss)

  $ 3,555     $ 4,625

 

       

 

 

 

From

December 14, 2011 (Inception)

to March 31,

2014 As Previously Reported

 

 

From

December 14, 2011 (Inception)

to March 31,

2014 As Restated

 

 

   

Net loss

 

$

(13,145

)

 

$

(15,199

)

 

     

Comprehensive loss

 

$

(13,145

)

 

$

(15,199

)

 

     

 

 

Unaudited Condensed Consolidated Statement of Changes in Stockholders’ Deficit Data

(in thousands)

 

   

As Previously Reported

   

As Restated

 

Net income (loss) for the three-months ended March 31,2014

  $ 3,555     $ 4,625

 

Accumulated deficit at March 31, 2014

  $ (13,145

)

  $ (15,199

)

Total Stockholders’ deficit at March 31, 2014

  $ (7,212

)

  $ (9,266

)

 

 

Unaudited Condensed Consolidated Statements of Cash Flows Data

(in thousands) 

 

   

For the Three-Months

Ended

March 31,

2014 As Previously Reported

   

For the Three-Months

Ended

March 31,

2014 As Restated

 

Cash flows from operating activities:

               

Net income (loss)

  $ 3,555     $ 4,625

 

Adjustments to reconcile net loss to net cash used in operating activities:

               

Change in fair value of conversion option of the convertible notes

  $     $ (1,070

 

   

For the Period from December 14, 2011 (Inception) to

March 31,

2014 As Previously Reported

   

For the Period from December 14, 2011 (Inception) to

March 31,

2014 As Restated

 
                 

Cash flows from operating activities:

               

Net loss

  $ (13,145

)

  $ (15,199

)

Adjustments to reconcile net loss to net cash used in operating activities:

               
Non-cash interest expense   $ 4,445     $ 7,206  

Change in fair value of conversion option of the convertible notes

  $     $ (707

 

 
 

 

 

The Company plans to file an amended Annual Report on Form 10-K for the year ended December 31, 2013 and an amended Quarterly Report on Form 10-Q for the three-months ended March 31, 2014 to include the audited consolidated financial statements for the year ended December 31, 2013 and for the period from December 14, 2011 (Inception) to December 31, 2013 and the unaudited condensed consolidated financial statements for the three-months ended March 31, 2014 and the period from December 31, 2011 (Inception) to March 31, 2014 and related disclosures reflecting the correction of the errors described above and their related effects as soon as practicable.

 

The Board and the Company’s management have discussed the matters in this Current Report on Form 8-K with its independent registered public accounting firm, EisnerAmper LLP.

 

Cautionary Note Regarding Forward-Looking Statements

 

Information contained in this Current Report on Form 8-K, other than historical information, may be considered “forward-looking statements.” Forward-looking statements involve known and unknown risks, assumptions, uncertainties, and other factors. Statements made in the future tense, and statements using words such as “anticipates,” “will,” “plans,” “may,” “can,” “could,” “should,” “believe,” “think” or similar expressions are intended to identify forward-looking statements, including statements about the Company’s expectations in regard to the impact the errors described above will have on its audited financial statements for the year ended December 31, 2013 and unaudited condensed consolidated financial statements for the three-months ended March 31, 2014, the anticipated filing of the Amended 10-K and Amended 10-Q, and the filing of its Quarterly Report on Form 10-Q for the three and six-months ended June 2014. Forward-looking statements are not a guarantee of performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and are beyond the Company’s control, and which risks and uncertainties have been described in greater detail in the Company’s filings with the Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from those expressed in or implied by the forward-looking statements, and therefore should be carefully considered. Factors that could cause or contribute to such differences include: the review of the Company’s accounting, accounting policies and internal control over financial reporting; the preparation of and the audit or review, as applicable, of the Original 10-K and Original 10-Q, the Amended 10-K and Amended10-Q, and 10-Q and the Company’s other filings with the Securities and Exchange Commission; and the subsequent discovery of additional adjustments to the Company’s previously issued financial statements. Actual events or results may differ materially from the Company’s expectations. In addition, the Company’s financial results and stock price may suffer as a result of this review and any subsequent determinations from this process or any actions taken by governmental or other regulatory bodies as a result of this process. The Company cautions you not to place undue reliance on the forward-looking statements, which speak only as of the date of this Report or an earlier date as may be indicated. The Company disclaims any obligation to update any of these forward-looking statements as a result of new information, future events, or otherwise, except as expressly required by law.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: August 19, 2014

 

 

 

 

  

By:

/s/ Michael E. Krawitz

 

 

Michael E. Krawitz

 

 

Title: Chief Legal and Financial Officer

 

VeriTeQ (CE) (USOTC:VTEQ)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more VeriTeQ (CE) Charts.
VeriTeQ (CE) (USOTC:VTEQ)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more VeriTeQ (CE) Charts.